Skip to main content

Placental Adenosine Signaling in the Pathophysiology of Preeclampsia

  • Chapter
  • First Online:

Part of the book series: Comprehensive Gynecology and Obstetrics ((CGO))

Abstract

Impairment in placental development and function is known to be associated with the pathophysiology of preeclampsia. However, placenta-specific molecular basis leading to preeclampsia remains to be fully understood. Adenosine, an endogenous nucleotide, is a signaling molecule that is induced under various pathological conditions including hypoxia, energy depletion, and inflammation and contributes to various diseases. Recent report form Iriyama et al. revealed that a local increase of adenosine in the placenta is sufficient to trigger key features of preeclampsia by using mouse models, and adenosine was identified as one of pathogenic factors for preeclampsia. This chapter is to summarize current progress and the significance of adenosine signaling in different disease states and to detail the findings of enhanced placental adenosine signaling in the pathophysiology of preeclampsia.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet. 2001;357(9249):53–6. Epub 2001/02/24.

    Article  CAS  PubMed  Google Scholar 

  2. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376(9741):631–44. Epub 2010/07/06.

    Article  PubMed  Google Scholar 

  3. Young BC, Levine RJ, Karumanchi SA. Pathogenesis of preeclampsia. Annu Rev Pathol. 2010;5:173–92. Epub 2010/01/19.

    Article  CAS  PubMed  Google Scholar 

  4. Ahmed A, Rahman M, Zhang X, Acevedo CH, Nijjar S, Rushton I, et al. Induction of placental heme oxygenase-1 is protective against TNFalpha-induced cytotoxicity and promotes vessel relaxation. Mol Med. 2000;6(5):391–409. Epub 2000/08/22.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Cudmore M, Ahmad S, Al-Ani B, Fujisawa T, Coxall H, Chudasama K, et al. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation. 2007;115(13):1789–97. Epub 2007/03/29.

    Article  CAS  PubMed  Google Scholar 

  6. Wang K, Ahmad S, Cai M, Rennie J, Fujisawa T, Crispi F, et al. Dysregulation of hydrogen sulfide producing enzyme cystathionine gamma-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia. Circulation. 2013;127(25):2514–22. Epub 2013/05/25.

    Article  CAS  PubMed  Google Scholar 

  7. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(5):649–58. Epub 2003/03/06.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Ahmad S, Ahmed A. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res. 2004;95(9):884–91. Epub 2004/10/09.

    Article  CAS  PubMed  Google Scholar 

  9. Lynch AM, Salmon JE. Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications. Placenta. 2010;31(7):561–7. Epub 2010/04/30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Zhou CC, Zhang Y, Irani RA, Zhang H, Mi T, Popek EJ, et al. Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat Med. 2008;14(8):855–62. Epub 2008/07/29.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Iriyama T, Sun K, Parchim NF, Li J, Zhao C, Song A, et al. Elevated placental adenosine signaling contributes to the pathogenesis of preeclampsia. Circulation. 2015;131(8):730–41. Epub 2014/12/30.

    Article  CAS  PubMed  Google Scholar 

  12. Chen JF, Eltzschig HK, Fredholm BB. Adenosine receptors as drug targets—what are the challenges? Nat Rev Drug Discov. 2013;12(4):265–86. Epub 2013/03/29.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Karmouty-Quintana H, Xia Y, Blackburn MR. Adenosine signaling during acute and chronic disease states. J Mol Med. 2013;91(2):173–81. Epub 2013/01/24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Liu H, Xia Y. Beneficial and detrimental role of adenosine signaling in diseases and therapy. J Appl Physiol. 2015;119(10):1173–82. Epub 2015/09/01.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Zhang Y, Xia Y. Adenosine signaling in normal and sickle erythrocytes and beyond. Microbes Infect. 2012;14(10):863–73. Epub 2012/05/29.

    Article  CAS  PubMed  Google Scholar 

  16. Fredholm BB, IJzerman AP, Jacobson KA, Linden J, Muller CE. International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors—an update. Pharmacol Rev. 2011;63(1):1–34. Epub 2011/02/10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev. 2001;53(4):527–52. Epub 2001/12/06.

    CAS  PubMed  Google Scholar 

  18. Salsoso R, Farias M, Gutierrez J, Pardo F, Chiarello DI, Toledo F, et al. Adenosine and preeclampsia. Mol Aspects Med. 2017;55:126–39. Epub 2017/01/17.

    Article  CAS  PubMed  Google Scholar 

  19. Fredholm BB, Irenius E, Kull B, Schulte G. Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochem Pharmacol. 2001;61(4):443–8. Epub 2001/02/28.

    Article  CAS  PubMed  Google Scholar 

  20. Zhou Y, Schneider DJ, Morschl E, Song L, Pedroza M, Karmouty-Quintana H, et al. Distinct roles for the A2B adenosine receptor in acute and chronic stages of bleomycin-induced lung injury. J Immunol. 2011;186(2):1097–106. Epub 2010/12/15.

    Article  CAS  PubMed  Google Scholar 

  21. Zhang Y, Dai Y, Wen J, Zhang W, Grenz A, Sun H, et al. Detrimental effects of adenosine signaling in sickle cell disease. Nat Med. 2011;17(1):79–86. Epub 2010/12/21.

    Article  CAS  PubMed  Google Scholar 

  22. Ohta A, Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature. 2001;414(6866):916–20. Epub 2002/01/10.

    Article  CAS  PubMed  Google Scholar 

  23. Sitkovsky M, Lukashev D. Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. Nat Rev Immunol. 2005;5(9):712–21. Epub 2005/08/20.

    Article  CAS  PubMed  Google Scholar 

  24. Shryock JC, Snowdy S, Baraldi PG, Cacciari B, Spalluto G, Monopoli A, et al. A2A-adenosine receptor reserve for coronary vasodilation. Circulation. 1998;98(7):711–8. Epub 1998/08/26.

    Article  CAS  PubMed  Google Scholar 

  25. Eckle T, Faigle M, Grenz A, Laucher S, Thompson LF, Eltzschig HK. A2B adenosine receptor dampens hypoxia-induced vascular leak. Blood. 2008;111(4):2024–35. Epub 2007/12/07.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Eckle T, Fullbier L, Wehrmann M, Khoury J, Mittelbronn M, Ibla J, et al. Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury. J Immunol. 2007;178(12):8127–37. Epub 2007/06/06.

    Article  CAS  PubMed  Google Scholar 

  27. Karmouty-Quintana H, Zhong H, Acero L, Weng T, Melicoff E, West JD, et al. The A2B adenosine receptor modulates pulmonary hypertension associated with interstitial lung disease. FASEB J. 2012;26(6):2546–57. Epub 2012/03/15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Sun CX, Zhong H, Mohsenin A, Morschl E, Chunn JL, Molina JG, et al. Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury. J Clin Invest. 2006;116(8):2173–82. Epub 2006/07/15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Karmouty-Quintana H, Weng T, Garcia-Morales LJ, Chen NY, Pedroza M, Zhong H, et al. Adenosine A2B receptor and hyaluronan modulate pulmonary hypertension associated with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2013;49(6):1038–47. Epub 2013/07/17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Dai Y, Zhang W, Wen J, Zhang Y, Kellems RE, Xia Y. A2B adenosine receptor-mediated induction of IL-6 promotes CKD. J Am Soc Nephrol. 2011;22(5):890–901. Epub 2011/04/23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Zhang W, Zhang Y, Wang W, Dai Y, Ning C, Luo R, et al. Elevated ecto-5′-nucleotidase-mediated increased renal adenosine signaling via A2B adenosine receptor contributes to chronic hypertension. Circ Res. 2013;112(11):1466–78. Epub 2013/04/16.

    Article  CAS  PubMed  Google Scholar 

  32. Mi T, Abbasi S, Zhang H, Uray K, Chunn JL, Xia LW, et al. Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling. J Clin Invest. 2008;118(4):1491–501. Epub 2008/03/15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Chan ES, Fernandez P, Merchant AA, Montesinos MC, Trzaska S, Desai A, et al. Adenosine A2A receptors in diffuse dermal fibrosis: pathogenic role in human dermal fibroblasts and in a murine model of scleroderma. Arthritis Rheum. 2006;54(8):2632–42. Epub 2006/07/28.

    Article  CAS  PubMed  Google Scholar 

  34. Chan ES, Montesinos MC, Fernandez P, Desai A, Delano DL, Yee H, et al. Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis. Br J Pharmacol. 2006;148(8):1144–55. Epub 2006/06/20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Melani A, Gianfriddo M, Vannucchi MG, Cipriani S, Baraldi PG, Giovannini MG, et al. The selective A2A receptor antagonist SCH 58261 protects from neurological deficit, brain damage and activation of p38 MAPK in rat focal cerebral ischemia. Brain Res. 2006;1073–1074:470–80. Epub 2006/01/31.

    Article  PubMed  Google Scholar 

  36. Chen JF, Huang Z, Ma J, Zhu J, Moratalla R, Standaert D, et al. A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J Neurosci. 1999;19(21):9192–200. Epub 1999/10/26.

    CAS  PubMed  Google Scholar 

  37. Kalda A, Yu L, Oztas E, Chen JF. Novel neuroprotection by caffeine and adenosine A(2A) receptor antagonists in animal models of Parkinson’s disease. J Neurol Sci. 2006;248(1–2):9–15. Epub 2006/06/30.

    Article  CAS  PubMed  Google Scholar 

  38. Yoneyama Y, Suzuki S, Sawa R, Takeuchi T, Kobayashi H, Takei R, et al. Changes in plasma adenosine concentrations during normal pregnancy. Gynecol Obstet Invest. 2000;50(3):145–8. Epub 2000/10/03.

    Article  CAS  PubMed  Google Scholar 

  39. Yoneyama Y, Suzuki S, Sawa R, Yoneyama K, Power GG, Araki T. Increased plasma adenosine concentrations and the severity of preeclampsia. Obstet Gynecol. 2002;100(6):1266–70. Epub 2002/12/07.

    CAS  PubMed  Google Scholar 

  40. Yoneyama Y, Suzuki S, Sawa R, Otsubo Y, Miura A, Kuwabara Y, et al. Plasma 5′-nucleotidase activities and uric acid levels in women with pre-eclampsia. Gynecol Obstet Invest. 2002;54(3):168–71. Epub 2003/02/07.

    Article  CAS  PubMed  Google Scholar 

  41. Matsubara S, Sato I. Plasma adenosine levels and P-selectin expression on platelets in preeclampsia. Obstet Gynecol. 2001;98(2):354–5. Epub 2001/08/21.

    Article  CAS  PubMed  Google Scholar 

  42. Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol. 2014;10(8):466–80. Epub 2014/07/09.

    Article  CAS  PubMed  Google Scholar 

  43. Espinoza J, Espinoza AF, Power GG. High fetal plasma adenosine concentration: a role for the fetus in preeclampsia? Am J Obstet Gynecol. 2011;205(5):485.e24–7. Epub 2011/08/23.

    Article  CAS  Google Scholar 

  44. von Versen-Hoynck F, Rajakumar A, Bainbridge SA, Gallaher MJ, Roberts JM, Powers RW. Human placental adenosine receptor expression is elevated in preeclampsia and hypoxia increases expression of the A2A receptor. Placenta. 2009;30(5):434–42. Epub 2009/03/24.

    Article  Google Scholar 

  45. St Hilaire C, Carroll SH, Chen H, Ravid K. Mechanisms of induction of adenosine receptor genes and its functional significance. J Cell Physiol. 2009;218(1):35–44. Epub 2008/09/04.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Takayuki Iriyama M.D., Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Iriyama, T., Xia, Y. (2018). Placental Adenosine Signaling in the Pathophysiology of Preeclampsia. In: Saito, S. (eds) Preeclampsia. Comprehensive Gynecology and Obstetrics. Springer, Singapore. https://doi.org/10.1007/978-981-10-5891-2_6

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-5891-2_6

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-5890-5

  • Online ISBN: 978-981-10-5891-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics